Table 4 Distribution of Spa types according to antibiotic non-susceptibility phenotypes for MRSA isolates (n = 1467)
Spa type | Antibiotic non-susceptibility phenotype | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azithromycin | Erythromycin | Clindamycin | Oxacillin | Cefoxitin | Penicillin | Trimethoprim/ Sulfamethoxazole | Daptomycin | Linezolid | Tetracycline | Rifampin | Ciprofloxacin | Levofloxacin | Moxyfloxacin | Gentamicin | |
t012 (n = 84) | 28 (1.90%) | 81 (5.52%) | 71 (4.83%) | 84 (5.72%) | 84 (5.72%) | 84 (5.72%) | 11 (0.74%) | 0 | 4 (0.27%) | 14 (0.95%) | 7 (0.47%) | 84 (5.72%) | 84 (5.72%) | 83 (5.65%) | 17 (1.15%) |
t018 (n = 9) | 4 (0.27%) | 8 (0.54%) | 7 (0.47%) | 8 (0.54%) | 9 (0.61%) | 9 (0.61%) | 0 | 0 | 0 | 1 (0.06%) | 1 (0.06%) | 9 (0.61%) | 9 (0.61%) | 9 (0.61%) | 2 (0.13%) |
t032 (n = 24) | 4 (0.27%) | 12 (0.81%) | 3 (0.20) | 24 (1.63%) | 24 (1.63%) | 24 (1.63%) | 1 (0.06%) | 0 | 0 | 2 (0.13%) | 43 (2.93%) | 23 (1.56%) | 23 (1.56%) | 23 (1.56%) | 3 (0.20) |
t037 (n = 697) | 327 (22.29%) | 690 (47.03%) | 81 (5.52%) | 693 (47.23%) | 695 (47.37%) | 698 (47.58%) | 659 (44.92%) | 5 (0.34%) | 1 (0.06%) | 679 (46.28%) | 0 | 691 (47.10) | 688 (46.89%) | 690 (47.03%) | 681 (46.42%) |
t045 (n = 131) | 53 (3.6%) | 130 (8.86%) | 13 (0.88%) | 130 (8.86%) | 130 (8.86%) | 130 (8.86%) | 11 (0.74%) | 2 (0.13%) | 4 (0.27%) | 18 (1.22%) | 6 (0.40%) | 25 (1.70%) | 24 (1.63%) | 26 (1.77%) | 123 (8.38%) |
t064 (n = 49) | 21 (1.43%) | 29 (1.97%) | 0 | 49 (3.34%) | 49 (3.34%) | 49 (3.34%) | 44 (2.99%) | 0 | 0 | 47 (3.20%) | 47 (3.20%) | 30 (2.04%) | 25 (1.70_ | 26 (1.77%) | 47 (3.20%) |
t1257 (n = 269) | 79 (5.3%) | 164 (11.17) | 14 (0.95%) | 268 (18.26%) | 268 (18.26%) | 268 (18.26%) | 249 (16.97%) | 0 | 2 (0.13%) | 263 (17.92) | 255 (17.38%) | 264 (17.99%) | 231 (15.74%) | 231 (15.74%) | 252 (17.17%) |
t1443 (n = 14) | 1 (0.06%) | 1 (0.06%) | 0 | 14 (0.95%) | 13 (0.88%) | 14 (0.95%) | 13 (0.88%) | 0 | 0 | 13 (0.88%) | 14 (0.95%) | 13 (0.88%) | 13 (0.88%) | 13 (0.88%) | 13 (0.88%) |
t1476 (n = 12) | 0 | 5 | 0 | 12 (0.81%) | 12 (0.81%) | 12 (0.81%) | 2 (0.13%) | 0 | 0 | 9 (0.61%) | 0 | 10 (0.68%) | 7 (0.47%) | 7 (0.47%) | 11 (0.74%) |
t1971 (n = 23) | 2 (0.13%) | 19 (1.29%) | 1 (0.06%) | 23 (1.56%) | 23 (1.56%) | 23 (1.56%) | 23 (1.56%) | 0 | 0 | 23 (1.56%) | 23 (1.56%) | 23 (1.56%) | 21 (1.42%) | 21 (1.42%) | 23 (1.56%) |
Novel spa types (n = 38) | 9 (0.61%) | 24 (1.63%) | 7 (0.47%) | 37 (2.52%) | 37 (2.52%) | 38 (2.59%) | 23 (1.56%) | 0 | 0 | 25 (1.70%) | 16 (1.09%) | 31 (2.11%) | 29 (1.97%) | 27 (1.84%) | 27 (1.84%) |
Untypeable (n = 5) | 3 (0.20%) | 4 (0.27%) | 1 (0.06%) | 5 (0.34%) | 5 (0.34%) | 5 (0.34%) | 3 (0.20%) | 0 | 0 | 3 (0.20%) | 1 (0.06%) | 4 (0.27%) | 4 (0.27%) | 3 (0.20%) | 3 (0.20%) |